FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C702 MODULE

MDR report key: 22134916 · Received June 3, 2025

Report

Report Number
1823260-2025-01713
Event Type
Malfunction
Date Received
June 3, 2025
Date of Event
May 8, 2025
Report Date
June 4, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

E1 INITIAL REPORTER ESTABLISHMENT NAME: (B)(6) HOSPITAL. THE REAGENT LOT NUMBER IS 841368. THE EXPIRATION DATE WAS NOT PROVIDED. THE FIELD SERVICE REPRESENTATIVE REPLACED THE REAGENT PROBES AND THE CUVETTE WASHING STATION'S TUBING. HE PERFORMED ADJUSTMENTS AND CHECKS, AN INCUBATION WATER EXCHANGE, AND CELL BLANK MEASUREMENTS WITH ACCEPTABLE RESULTS. AFTER SERVICE, NO ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Additional Manufacturer Narrative · 0

IN THE INITIAL MEDWATCH, THE FIRST LINE OF B5 DESCRIBE EVENT OR PROBLEM SHOULD HAVE BEEN: "THERE WAS AN ALLEGATION OF QUESTIONABLE CALCIUM GEN.2 RESULTS FOR 2 PATIENT SAMPLES ON A COBAS 8000 C702 MODULE." INSTEAD OF: "THERE WAS AN ALLEGATION OF QUESTIONABLE CALCIUM RESULTS FOR 2 PATIENT SAMPLES ON A COBAS 8000 C702 MODULE."

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE CALCIUM RESULTS FOR 2 PATIENT SAMPLES ON A COBAS 8000 C702 MODULE. PATIENT 1: THE INITIAL RESULT WAS 1.51 MMOL/L, AND THE REPEATED RESULT WAS 2.09 MMOL/L. PATIENT 2: THE INITIAL RESULT WAS 1.42 MMOL/L, AND THE REPEATED RESULT WAS 2.16 MMOL/L. THE REPEATED RESULTS WERE BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1065008 COBAS 8000 C702 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown